Nina Pryakhina

Nina Pryakhina


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2022 in Processes
Verified
Journal Article
Open access
PDF file
MSMikhail Syromyatnikov
Mikhail Syromyatnikov
ENEkaterina Y. Nesterova
Ekaterina Y. Nesterova
MGMaria I. Gladkikh
Maria I. Gladkikh
ATAnna Aleksandrovna Tolkacheva
Anna Aleksandrovna Tolkacheva
OBOlga Владимировна Bondareva
Olga Владимировна Bondareva
Vasily N. PopovVasily N. Popov
Vasily N. Popov
Microbial bioformulations, due to their positive impact on the growth and development of plants, as well as the absence of harmful effects on the environment and humans, have a vast potential for mass introduction into agriculture. Assessing the quality of bioformulations, especially complex ones, is a difficult task. In this study, we show that high-throughput sequencing can be an effective tool for the quality control and safety of microbial bioformulations. By the method of high-throughput sequencing on the MiSeq platform, we studied 20 samples of commercially available microbial bioformulations. In parallel with this, bioformulations were studied by classical microbiological methods. The analysis showed the presence of extraneous undeclared bacterial genera by the manufacturer. Only 10% of the bioformulations fully corresponded to the commercial composition, and another 10% of the bioformulations did not contain the bacteria declared by the manufacturer in their composition at all. The bacterial composition of 80% of the bioformulations partially corresponded to the composition indicated on the package. The most frequent microbial bioformulations contaminants were Enterococcus, Lactobacillaceae, Klebsiella, Escherichia-Shigella and Allorhizobium-Neorhizobium-Pararhizobium-Rhizobium. Universal methods for the quality control of bioformulations are needed. The advantages of high-throughput sequencing for the evaluation of bioformulations are considered in this work.

10 February 2022 in Proceedings of the Voronezh State University of Engineering Technologies
Verified
Journal Article
Open access
PDF file
OBOlga Владимировна Bondareva
Olga Владимировна Bondareva
ATAnna Aleksandrovna Tolkacheva
Anna Aleksandrovna Tolkacheva
NPNina Pryakhina
Nina Pryakhina
GSG. P. Shuvaeva
G. P. Shuvaeva
DCD. A. Cherenkov
D. A. Cherenkov
OKOlga Korneeva
Olga Korneeva
Lactic acid is used in various industries: chemical, food, cosmetic, pharmaceutical, agriculture and polymer production. 40% of the domestic market demand for lactic acid is met through imports, while the main methods for producing lactic acid are microbiological or synthetic. The most rational is microbiological synthesis, however, when it is implemented, valuable sugar-containing substrates (crystalline sucrose, molasses, sugar syrup) are used, which significantly affects the cost of the final product. There was an obvious need to search for new technologies for the production of lactic acid. Prospective and cost-effective is the processing of whey into lactic acid using bacterial fermentation of the lactose contained in the whey. The aim of the study is to screen cultures of microorganisms capable of fermenting lactose contained in milk whey and to select the composition of the medium that provides the maximum yield of lactic acid. Strains of lactic acid bacteria were used in the experiment: Leuconostocmesenteroides subsp. mesenteroides 122 (B1699), Lactobacillus brevis B78 (B5728), Lactobacillus plantarum K9 (B5466), Lactobacillus casei C1 (B5726), Lactobacillus acidophilus (B9012), Lactobacillus paracasei BT 24/88 (B6253), Lactobacillus paracasei 139 (B2430), obtained from the Russian National Collection of Industrial Microorganisms (Scientific Center "Kurchatov Institute" -Research Institute for Genetics and Selection of Industrial Microorganisms). The authors determined the optimal composition of the medium for the biosynthesis of lactic acid by selecting the concentrations of yeast autolysate and salt solution that provide the maximum yield of lactic acid. The authors also selected the optimal duration of lactic acid biosynthesis. The study of the acid-forming ability of strains of lactic acid bacteria showed that of the strains studied, Lactobacillus casei C1 (B5726) showed the greatest ability to ferment lactose by synthesizing lactic acid, which correlates with the data on assimilation of lactose by the culture. The optimal cultivation time (132 h) and the concentration of yeast lysate (5%) in a nutrient medium based on curd whey were selected. With optimal parameters, the maximum concentration of lactic acid in the culture liquid of Lactobacillus casei C1 (B5726) was 54.77 g / L, which is comparable with the currently used producers in the industrial production of lactic acid.

30 December 2025 in Proceedings of the Voronezh State University of Engineering Technologies
Verified
Journal Article
Open access
PDF file
ATAnna Aleksandrovna Tolkacheva
Anna Aleksandrovna Tolkacheva
NPNina Pryakhina
Nina Pryakhina
OBOlga Владимировна Bondareva
Olga Владимировна Bondareva
EBEkaterina Bogdanova
Ekaterina Bogdanova
YKY. P. Kuznetsova
Y. P. Kuznetsova
OKO. S. Korneeva
O. S. Korneeva
The creation of probiotic fermented milk products, additionally enriched with probiotics, capable of maintaining their viability during storage of the finished product and under the harsh conditions of the gastrointestinal tract (GIT) is a pressing issue. In this study, capsules of alginate, pectin, and κ-carrageenan, additionally coated with chitosan, were produced using an emulsion method, encapsulating cells of the probiotic strain Weizmannia coagulanS. Samples of the probiotic fermented milk product containing free and encapsulated W. coagulans cells were prepared, and the physicochemical, microbiological, and sensory characteristics of the finished product were analyzed. When testing the viability of the capsules in the finished product under simulated GIT conditions, it was found that encapsulated cells demonstrated a high survival rate compared to free cellS. For capsules made of an alginate-pectin mixture (A-P), it was 9.92 Log10 CFU/ml, for capsules made of an alginate-pectin-carrageenan mixture (A-P-C), 10.33 Log10 CFU/ml, the viability of free cells dropped to 2.17 Log10 CFU/ml. Encapsulated and free probiotic cells during storage of a fermented milk product had a significant impact on various characteristics of the finished product. A tendency towards an increase in titratable acidity, a decrease in viscosity, and an increase in syneresis was observed. The viability of free probiotic cells during 21 days of storage decreased by 7.13 Log10 CFU/ml, while the viability of encapsulated cells dropped by only 1.35 Log10 CFU/ml for A-P capsules and by 2.92 Log10 CFU/ml for A-P-C capsuleS. The addition of free and encapsulated cells had little effect on the sensory characteristics of the finished product at the end of its shelf life. The results showed that probiotic encapsulation significantly increased bacterial survival both in the finished product during storage and under simulated gastrointestinal conditions.